欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
NO/H/0314/003
药品名称
Atsteinar
活性成分
Atorvastatin calcium salt 41.44 mg
剂型
Film-coated tablet
上市许可持有人
Actavis Group PTC ehf. Reykjavikurvegur 76-78 220 Hafnarfjordur Iceland
参考成员国 - 产品名称
Norway (NO)
互认成员国 - 产品名称
许可日期
2009/02/25
最近更新日期
2024/11/01
药物ATC编码
C10AA05 atorvastatin
申请类型
TypeLevel1：
[not specified]
TypeLevel2：
[not specified]
TypeLevel3：
[not specified]
TypeLevel4：
[not specified]
TypeLevel5：
[not specified]
附件文件下载
Final PL
|
atorvastatin_no_h_0314_001_003_pil_01_07_24
Date of last change:2024/11/01
Final SPC
|
atorvastatin_no_h_0314_001_003_smpc_01_07_24
Date of last change:2024/11/01
Final Labelling
|
Atorvastatin_DK_H_1413_001_OuP_ImP_25_07_18
Date of last change:2024/09/06
Final Labelling
|
Atorvastatin_DK_H_1413_002_OuP_ImP_25_07_18
Date of last change:2024/09/06
Final Labelling
|
Atorvastatin_DK_H_1413_003_OuP_ImP_25_08_18
Date of last change:2024/09/06
Final Labelling
|
Atorvastatin_DK_H_1413_004_OuP_ImP_25_07_18
Date of last change:2024/09/06
PubAR
|
parmod5_dk1413atsteinar_pdf
Date of last change:2024/09/06
Final Product Information
|
PI_Atorvastatin_DK_H_1413_01_04_P001_v4_1_20180131_CL
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase